Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(33.3%)
Phase 2
2(33.3%)
Phase 4
1(16.7%)
Phase 3
1(16.7%)
6Total
N/A(2)
Phase 2(2)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07351149Recruiting

Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery

Role: collaborator

NCT06376487Not ApplicableRecruiting

Pulmonary Aeration and Muscle Thickening Fraction: Association of Electrical Impedance Tomography and Ultrasound

Role: collaborator

NCT00199134Phase 2Completed

FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole

Role: collaborator

NCT01003392Unknown

Influence of Coffee on the Health and on the Heart of Normal, Diabetics e Coronary Artery Disease Patients

Role: collaborator

NCT00097110Phase 3Completed

RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil

Role: collaborator

NCT01456273Not ApplicableUnknown

From the Biomedical to the Biopsychosocial Model, From Theory to Practice

Role: collaborator

NCT00771225Phase 4Unknown

National,Multicentric Randomised Study of the Correction of Genital Prolapse With Fascial Repair or Mesh-Prolift

Role: collaborator

NCT00162812Phase 2Terminated

Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin

Role: collaborator

All 8 trials loaded